Evidence map›Paper›PMID 35449501›Full record

ReviewReproductive sciences (Thousand Oaks, Calif.)2022

Clinical Characteristics and Outcomes of COVID-19 During Pregnancy-a Retrospective Cohort Study.

Sarah Dollinger, Rita Zlatkin, Chen Jacoby, Anat Shmueli, Shiri Barbash-Hazan, Rony Chen, Hadas Zafrir Danieli, Shay Sukenik, Eran Hadar, Arnon Wiznitzer

Open access · bronzeAbstract readReview
In one paragraph

Review in Reproductive sciences (Thousand Oaks, Calif.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sarah DollingerRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel. sarahdollinger@gmail.com.ORCID 0000-0002-0040-2574
Rita ZlatkinRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Chen JacobyRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Anat ShmueliRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Shiri Barbash-HazanRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Rony ChenRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Hadas Zafrir DanieliRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Shay SukenikRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Eran HadarRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Arnon WiznitzerRabin Medical Center, Helen Schneider Hospital for Women, 39 Jabotinsky Street, 4941492, Petah Tikva, Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The course of COVID-19 has been shown to be worse in pregnant women compared with their non-pregnant counterparts. The aim of this study is to share our experience treating pregnant women with COVID-19 and to establish a cohort for future studies of the long-term effects of the disease. We reviewed medical records of all SARS-CoV-2-positive pregnant women who were treated at our hospital for any reason, be it COVID-19 related or not, between April 2020 and February 2021. We extracted data regarding medical history, course of pregnancy, delivery, and neonatal outcomes. A total of 193 SARS-CoV-2-positive pregnant women were treated at our establishment during the study period, half of which were asymptomatic. Sixteen were hospitalized for COVID-19 symptoms, the most common being fatigue/malaise (58%) and cough (48%). Three women required mechanical ventilation and extracorporeal membrane oxygenation treatment. One hundred forty-four SARS-CoV-2-positive women were delivered during the study period. Of them, 24 (17%) underwent induction of labor, and four (17%) were due to symptomatic COVID-19. One hundred fifteen (80%) experienced vaginal delivery, and 29 (20%) underwent cesarean delivery. Neonatal outcomes were favorable; only 2% of 5-min Apgar scores were < 7, and all umbilical cord pH levels were > 7.1. Six infants tested positive for SARS-CoV-2; they were all asymptomatic, and none required treatment for viral infection. COVID-19 during pregnancy is a disease with potential substantial adverse maternal and neonatal outcomes. There is still much unknown regarding the long-term effects of the disease on parturients and their offspring.

Indexed as

COVID-19Pregnancy Complications, InfectiousCohort StudiesFemaleHumansInfant, NewbornPregnancyPregnancy OutcomeRetrospective StudiesSARS-CoV-2COVID-19DeliveryNeonatal outcomesPregnancySARS-CoV-2

Identifiers

PMID35449501
PMCPMC9023045
OpenAlexW4224221187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.